GRANULOMATOUS POLYANGITIS (WEGENER’S GRANULOMATOSIS) IN THE PRACTICE OF A RHEUMATOGIST
This publication describes a patient diagnosed with Granulomatous polyangiitis (Wegener's granulomatosis), who was observed and treated for a long time by doctors of different specialties. Due to the ineffectiveness of long-term therapy for the disease, a thorough comprehensive analysis of clinical, laboratory and instrumental data was carried out in order to verify the diagnosis. The data presented in the article will be useful to representatives of practical healthcare, rheumatologists, visual diagnostic doctors and general practitioners.
Maya V. Goremykina1, https://orcid.org/0000-0002-5433-7771
Merey M. Yeshmukhamet1, https://orcid.org/0000-0002-3816-4305
Zhanar A. Ilyas1, https://orcid.org/0000-0002-3816-4305
Aigul M. Berekenova2, Bagdat B. Zhandarbekova2
1 NJSC “Semey Medical University”, The department of internal medicine and rheumatology,
Semey, Republic of Kazakhstan;
2 The University Hospital of the NJSC "Semey Medical University", Semey, Republic of Kazakhstan.
1. Lila A.M., Torraka P.F., Rocha S.P., Santiago C.M.R., Ferraz F.Kh. Granulematoz s poliangiitom, novaia nomenklatura dlia otcheta o granulematoze Vegenera // Dermatol. 2015. 90:101–3. – PubMed.
2. Komarmond S., Kakub P. Granulematoz s poliangiitom (Vegener): klinicheskie aspekty i lechenie // Autoimmun Rev. 2014. 13:1121–5. – PabMed
3. Alexandra Villa-Forte Cleveland Clinic Medical review. 06. 2022.
4. Bosch X., Guilabert A., Font J. Antineutrophil cytoplasmic antibodies // Lancet 2006. 368:404–18.
5. Guillevin L., Pagnoux C., Karras A. et al. French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCAassociated vasculitis // N Engl J Med. 2014. 371(19):1771-80. doi: 10.1056/NEJMoa1404231.
6. Hoffman G.S., Kerr G.S., Leavitt R.Y. et al. Wegener’s granulomatosis: an analysis of 158 patients // Ann Intern Med. 1992. 116(6):488–98. http://dx.doi.org/10.7326/0003- 4819-116-6-488.
7. Hoffman G.S., Kerr G.S., Leavitt R.Y. et al. Wegener granulomatosis: an analysis of 158 patients //. Ann Intern Med 1992. 116:488–98. 6.
8. Jennette J.C., Falk R.J., Bacon P.A., et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides // Arthritis Rheum. 2013. 65(1):1–11. DOI: 10.1002/ art.37715.
9. Jones R.B., Tervaert J.W., Hauser T. et al; European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis // N Engl J Med. 2010. 363(3):211-20. doi: 10.1056/NEJMoa0909169
10. Reinhold-Keller E., Beuge N., Latza U. et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients // ArthrRheum. 2000. 43:1021–32.
11. Seo P., Specks U., Keogh K.A. Efficacy of rituximab in limited Wegener’s granulomatosis with refractory granulomatous manifestations // J Rheumatol. 2008. 35(10): 2017-2023.
12. Stone J.H., Merkel P.A., Spiera R., et al. RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis // N Engl J Med. 2010;363(3):221-32. doi: 10.1056/NEJMoa0909905
13. Tiewsoh I., Dey B., Lyngdoh M., Lynrah K., Synrem E., Mitra A.J. Family Med Prim Care. 2020 30 ноября. 9 (11): 5783-5786: PMID: 33532434
14. Wiik A. Rational use of ANCA in the diagnosis of vasculitis // Rheumatology (Oxford). 2002. 41:481–3.
15. Watts R., Lane S., Hanslik T. et al. Development and validation of a consensus methodology for the classification of the ANCA-asso ciatedvasculitides and polyarteritisnodosa for epidemiological studies // Ann Rheum Dis. 2007. 66:222–7.
16. Yi E.S., Colby T.V. Wegener Granulomatosis // Semin Diagn Pathology. 2001. 18:34–46.
Number of Views: 62
Category of articles:
Clinical case
Bibliography link
Goremykina M.V., Yeshmukhamet M.M., Ilyas Zh.A., Berekenova A.M., Zhandarbekova B.B. Granulomatous Polyangitis (Wegener’s Granulomatosis) in the practice of a rheumatogist // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 6, pp. 275-279. doi 10.34689/SH.2023.25.6.030Related publications:
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES
GRANULOMATOUS POLYANGITIS (WEGENER’S GRANULOMATOSIS) IN THE PRACTICE OF A RHEUMATOGIST
VARIANT OF ADULT-ONSET STILL’SDISCASE: CASE REPORT
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2